Biocon Ltd 2019 AR2
The report highlights Biocon Limited's achievements during its 40th anniversary year, reporting a 31% growth in consolidated revenue to INR 56,588 million and a 143% increase in net profit to INR 9,053 million for FY19. The company expanded its global biosimilars footprint with key launches in the U.S. and Europe, serving nearly 2 million patients. On the sustainability front, Biocon achieved a total carbon footprint reduction of 103,200 tons of CO2, with renewable energy accounting for over 54% of its total power consumption. Additionally, the company continued its social impact through the Biocon Foundation, which recorded nearly 400,000 patient visits at its eLAJ Smart Clinics since launch.
Company: Biocon Ltd
Sector: Manufacturing
Country: India
Year: 2019
Type: AR2
Pages: 284
Back to company
Biocon Ltd
Annual Report
The report highlights Biocon Limited's achievements during its 40th anniversary year, reporting a 31% growth in consolidated revenue to INR 56,588 million and a 143% increase in net profit to INR 9,053 million for FY19. The company expanded its global biosimilars footprint with key launches in the U.S. and Europe, serving nearly 2 million patients. On the sustainability front, Biocon achieved a total carbon footprint reduction of 103,200 tons of CO2, with renewable energy accounting for over 54% of its total power consumption. Additionally, the company continued its social impact through the Biocon Foundation, which recorded nearly 400,000 patient visits at its eLAJ Smart Clinics since launch.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Published
Jun 23, 2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Renewable Energy
Employees